You are here

Article Text

Article menu
Download PDFPDF
PostScript
Correspondence
Dosing of intravenous immunoglobulin in COVID-19 vaccine-induced immune thrombocytopenia and thrombosis

https://doi.org/10.1136/jcp-2022-208377

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Handling editor Tahir S Pillay.

    • Contributors SAM conceived and wrote the first draft of the manuscript. SP critically reviewed and revised the manuscript. MF provided and validated data on immunoglobulin use in VITT.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests SAM chairs the immunoglobulin expert working group at NHS England.

    • Provenance and peer review Not commissioned; externally peer reviewed.